US-based biopharmaceutical company NexBio, Inc. has been awarded a $US6 million phase II Small Business Innovation Research (SBIR) grant by the US NIAID

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.485, 2005-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A grant totalling $US16.8 million has been awarded to AlphaVax to support the development of a vaccine against HIV infections

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 437, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Funding in the amount of $US1 million has been pledged by US-based pharmaceutical giant Wyeth

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 365, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

A unique form of infant leukaemia has been identified by US-based researchers.

By  

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The Global Fund for AIDS, Tuberculosis and Malaria has rejected the US's request for an emergency grant of $US50 million

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640-641, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

A $US4.55 million national screening programme for individuals aged 50 years has been launched in Singapore

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite